Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,084 | 14,717 | 15,944 | 16,886 | 17,600 |
| Receivables | 24 | 41 | 64 | 66 | 79 |
| TOTAL | $13,397 | $15,343 | $16,532 | $17,448 | $18,177 |
| Non-Current Assets | |||||
| PPE Net | 113 | 121 | 128 | 126 | 50 |
| Other Non-Current Assets | 25 | 26 | 20 | 20 | 20 |
| TOTAL | $138 | $146 | $148 | $146 | $70 |
| Total Assets | $13,535 | $15,489 | $16,680 | $17,594 | $18,247 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 181 | 317 | 220 | 230 | 146 |
| Accrued Expenses | 559 | 122 | 83 | 176 | 272 |
| TOTAL | $740 | $438 | $303 | $405 | $419 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 49 | 51 | 54 | 0 | 0 |
| TOTAL | $49 | $51 | $54 | $N/A | $N/A |
| Total Liabilities | $789 | $489 | $357 | $405 | $419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,572 | 12,567 | 12,564 | 12,528 | 12,528 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -13,860 | -11,483 | -9,899 | -8,954 | -8,219 |
| TOTAL | $12,746 | $15,000 | $16,323 | $17,188 | $17,828 |
| Total Liabilities And Equity | $13,535 | $15,489 | $16,680 | $17,594 | $18,247 |